| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Cepharanthine, a leukocyte proliferation drug, can promote the proliferation of bone marrow tissue, thereby increasing white blood cells. For leukopenia. It can increase leukocytes in peripheral blood. Animal experiments have found that it can significantly prevent leukopenia caused by mitomycin, but does not inhibit the anticancer effect of mitomycin. Its mechanism of action is to promote the proliferation of bone marrow tissue, thereby producing the effect of increasing white blood cells. For agranulocytosis caused by tumor chemotherapy, radiotherapy and leukopenia caused by other reasons.
|
English name: Cepharanthine Stephania Japonica Extract |
|
Testing terms |
Standards |
Results |
|
Assay |
95.0%~102.0% |
99.9% |
|
PH |
3.5~5.5 |
4.6 |
|
Appearance of solution |
0.5mol/L HCL≤2# 2mol/L NH4 OH≤2# |
1# 1# |
|
Water |
11.5%~14.5% |
13.2% |
|
Related substances |
Impurity (max.)≤1.0% |
0.13% |
|
Specific optical rotation |
+290''~+315'' |
+305° |
|
Sulfated ash |
≤1.0% |
0.1% |
|
N-N-Dimethylannline |
≤20ppm |
Never used in the production |
|
Methylen chloride |
≤600ppm |
296ppm |
|
|
≤320ppm |
155ppm |
|
|
≤3000ppm |
95ppm |
|
Conclusion:complies with EP 6th Standard. |
||
){kind=link}